- $2.85m
- $1.31m
- $2.00m
Brief: Bioatla Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Brief: Bioatla Inc Files For Offering Of Up To 9.75 Million Shares Of Common Stock
Bioatla Inc reports results for the quarter ended in September - Earnings Summary
U.S. STOCKS ON THE MOVE-Gold Fields, major U.S. banks, Monster Beverage
U.S. STOCKS ON THE MOVE-Silver miners, Luxury brands, TransMedics Group
Brief: Bioatla Announces $65 Million Underwritten Offering Of Its Common Stock
U.S. STOCKS ON THE MOVE-Hershey, Coinbase, Cardinal Health
BioAtla surges on additional data from lung cancer study
U.S. RESEARCH ROUNDUP-Altice USA, C4 Therapeutics, Lincoln National
Brief: Bioatla Reports Third Quarter 2022 Financial Results
Bioatla Inc expected to post a loss of 80 cents a share - Earnings Preview
Brief: Himalaya Therapeutics Announces Interim Phase 2 Results For Mecbotamab Vedotin
U.S. RESEARCH ROUNDUP- Axon Enterprise, Berkeley Lights, Minerva Surgical
Bioatla Inc reports results for the quarter ended in June - Earnings Summary
Bioatla Inc expected to post a loss of 69 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
U.S. RESEARCH ROUNDUP- Bioatla, BRF, Tegna
Brief: Bioatla Reports First Quarter 2022 Financial Results And Highlights Recent Progress